Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2013) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Journal of Experimental Pharmacology | journal | 0.129 Q4 | 23 | 1 | 3 | 166 | 2 | 3 | 0.50 | 166.00 |  |
| 2 | Journal of Receptor, Ligand and Channel Research | journal | 0.481 Q3 | 13 | 2 | 12 | 279 | 23 | 11 | 0.43 | 139.50 | |
| 3 | Clinical Medicine Insights: Therapeutics | journal | 0.117 Q4 | 11 | 13 | 105 | 1049 | 31 | 105 | 0.32 | 80.69 | |
| 4 | Core Evidence (discontinued) | journal | 0.685 Q2 | 29 | 7 | 29 | 442 | 82 | 28 | 3.63 | 63.14 | |
| 5 | Pharmacogenomics and Personalized Medicine | journal | 0.572 Q2 | 37 | 16 | 33 | 996 | 73 | 33 | 2.68 | 62.25 | |
| 6 | Infection and Drug Resistance | journal | 0.601 Q2 | 65 | 27 | 47 | 1454 | 123 | 46 | 2.77 | 53.85 | |
| 7 | Drug Design, Development and Therapy | journal | 0.979 Q2 | 94 | 146 | 114 | 7597 | 484 | 114 | 4.27 | 52.03 | |
| 8 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.701 Q2 | 64 | 51 | 71 | 2388 | 190 | 69 | 2.77 | 46.82 | |
| 9 | Biomarker Insights | journal | 0.793 Q2 | 40 | 16 | 52 | 643 | 141 | 52 | 2.39 | 40.19 | |
| 10 | Drug, Healthcare and Patient Safety | journal | 0.347 Q3 | 30 | 25 | 58 | 765 | 84 | 57 | 1.64 | 30.60 | |
| 11 | Perspectives in Medicinal Chemistry | journal | 0.121 Q4 | 17 | 0 | 5 | 0 | 2 | 5 | 0.00 | 0.00 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data